The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
IL33: Roles in Allergic Inflammation and Therapeutic Perspectives
Open accessAbstract
Interleukin (IL)-33 belongs to IL-1 cytokine family which is constitutively produced from the structural and lining cells including fibroblasts, endothelial cells, and epithelial cells of skin, gastrointestinal tract, and lungs that are exposed to the environment. Different from most cytokines that are actively secreted from cells, nuclear cytokine IL-33 is passively released during cell necrosis or when tissues are damaged, suggesting that it may function as an alarmin that alerts the immune system after endothelial or epithelial cell damage during infection, physical stress, or trauma. IL-33 plays important roles in type-2 innate immunity via activation of allergic inflammation-related eosinophils, basophils, mast cells, macrophages, and group 2 innate lymphoid cells (ILC2s) through its receptor ST2. In this review, we focus on the recent advances of the underlying intercellular and intracellular mechanisms by which IL-33 can regulate the allergic inflammation in various allergic diseases including allergic asthma and atopic dermatitis. The future pharmacological strategy and application of traditional Chinese medicines targeting the IL-33/ST2 axis for anti-inflammatory therapy of allergic diseases were also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: The cytokine interleukin-33 mediates anaphylactic shock
Pushparaj, P. N., Tay, H. K., H'ng, S. C., Pitman, N., Xu, D., McKenzie, A., Liew, F. Y., & Melendez, A. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901206106 · Cited by 285
RetractedSchmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J.-I., Ohtani, M., Fujii, H., & Koyasu, S. (2010) · Nature · doi:10.1038/nature08636 · Cited by 1,992
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K. A., Bucks, C., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 1,938
A large-scale, consortium-based genomewide association study of asthma
Moffatt, M. F., Gut, I. G., Demenais, F., Strachan, D. P., Bouzigon, E., Heath, S., von Mutius, E., Farrall, M., Lathrop, M., & Cookson, W. O. C. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906312 · Cited by 1,818
Moussion, C., Ortega, N., & Girard, J.-P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003331 · Cited by 1,179
The safety and side effects of monoclonal antibodies
Hansel, T. T., Kropshofer, H., Singer, T., Mitchell, J. A., & George, A. J. T. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3003 · Cited by 1,144
Systemically dispersed innate IL-13–expressing cells in type 2 immunity
Price, A. E., Liang, H.-E., Sullivan, B. M., Reinhardt, R. L., Eisley, C. J., Erle, D. J., & Locksley, R. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003988107 · Cited by 1,131
Helical Assembly in the MyD88-IRAK4-IRAK2 Complex in TLR/IL-1R Signalling
Lin, S.-C., Lo, Y.-C., & Wu, H. (2010) · Nature · doi:10.1038/nature09121 · Cited by 1,111 · cited 1×
“The IL-33/ST2 signaling pathway recruits adapter protein MyD88 to transduce intracellular signaling (105, 106).”
BackgroundGroup 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity
Brestoff, J. R., Kim, B. S., Saenz, S. A., Stine, R. R., Monticelli, L. A., Sonnenberg, G. F., Thome, J. J., Farber, D. L., Lutfy, K., Seale, P., et al. (2015) · Nature · doi:10.1038/nature14115 · Cited by 968 · cited 1×
“ILC2s are primarily localized at mucosal surfaces of lung, skin, gut and adipose tissues (51, 52) and play an important role in IL-33 associated allergic inflammatory diseases.”
BackgroundCarriere, V., Roussel, L., Ortega, N., Lacorre, D.-A., Americh, L., Aguilar, L., Bouche, G., & Girard, J.-P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606854104 · Cited by 966 · cited 2×
“Under the inactive state, IL-33 is harbored in the cell nuclei and associated with chromatin by a chromatin-binding motif, belonging to the cellular homeostasis and acting as a transcriptional repressor (2, 3).”
BackgroundHalim, T. Y. F., Steer, C. A., Mathä, L., Gold, M. J., Martinez-Gonzalez, I., McNagny, K. M., McKenzie, A. N. J., & Takei, F. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.011 · Cited by 949
IL‐1, IL‐18, and IL‐33 families of cytokines
Arend, W. P., Palmer, G., & Gabay, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00624.x · Cited by 912
Interleukin‐33 (IL‐33): A nuclear cytokine from the IL‐1 family
Cayrol, C., & Girard, J. (2018) · Immunological Reviews · doi:10.1111/imr.12619 · Cited by 879
(MCAAS), M. C. C. A. S., Ober, C., study, C. H. S. (. A. H., Genetics of Asthma in Latino Americans (GALA) Study, T. S. O. G.-E. A. A. I. L. A. (. A. T. S. O. A. A., Childhood Asthma Research and Education (CARE) Network, (CAMP), C. A. M. P., (SAPPHIRE), S. O. A. P. A. P. I. B. R.-E., Study, G. R. O. A. I. T. A. D. (., & Nicolae, D. L. (2011) · Nature Genetics · doi:10.1038/ng.888 · Cited by 833
Kurowska-Stolarska, M., Stolarski, B., Kewin, P., Murphy, G., Corrigan, C. J., Ying, S., Pitman, N., Mirchandani, A., Rana, B., van Rooijen, N., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901575 · Cited by 717
The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
Cayrol, C., & Girard, J.-P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812690106 · Cited by 707
IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy
Cayrol, C., & Girard, J.-P. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.09.004 · Cited by 699
Oliphant, C. J., Hwang, Y. Y., Walker, J. A., Salimi, M., Wong, S. H., Brewer, J. M., Englezakis, A., Barlow, J. L., Hams, E., Scanlon, S. T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.016 · Cited by 696
Mast cells as sources of cytokines, chemokines, and growth factors
Mukai, K., Tsai, M., Saito, H., & Galli, S. J. (2018) · Immunological Reviews · doi:10.1111/imr.12634 · Cited by 682
Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases
Lüthi, A. U., Cullen, S. P., McNeela, E. A., Duriez, P. J., Afonina, I. S., Sheridan, C., Brumatti, G., Taylor, R. C., Kersse, K., Vandenabeele, P., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.007 · Cited by 677
Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction
Gudbjartsson, D. F., Bjornsdottir, U. S., Halapi, E., Helgadottir, A., Sulem, P., Jonsdottir, G. M., Thorleifsson, G., Helgadottir, H., Steinthorsdottir, V., Stefansson, H., et al. (2009) · Nature Genetics · doi:10.1038/ng.323 · Cited by 677
Interleukin-33 in tissue homeostasis, injury, and inflammation
Molofsky, A. B., Savage, A. K., & Locksley, R. M. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.006 · Cited by 638
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
Griesenauer, B., & Paczesny, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00475 · Cited by 619
Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T Cells
Xu, D., Chan, W. L., Leung, B. P., Huang, F.-P., Wheeler, R., Piedrafita, D., Robinson, J. H., & Liew, F. Y. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.787 · Cited by 512
A novel IL-1 family cytokine, IL-33, potently activates human eosinophils
Cherry, W. B., Yoon, J., Bartemes, K. R., Iijima, K., & Kita, H. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.04.005 · Cited by 499
Kondo, Y., Yoshimoto, T., Yasuda, K., Futatsugi-Yumikura, S., Morimoto, M., Hayashi, N., Hoshino, T., Fujimoto, J., & Nakanishi, K. (2008) · International Immunology · doi:10.1093/intimm/dxn037 · Cited by 478
Pecaric-Petkovic, T., Didichenko, S. A., Kaempfer, S., Spiegl, N., & Dahinden, C. A. (2009) · Blood · doi:10.1182/blood-2008-05-157818 · Cited by 420
The Alarmin Interleukin-33 Drives Protective Antiviral CD8 + T Cell Responses
Bonilla, W. V., Fröhlich, A., Senn, K., Kallert, S., Fernandez, M., Johnson, S., Kreutzfeldt, M., Hegazy, A. N., Schrick, C., Fallon, P. G., et al. (2012) · Science · doi:10.1126/science.1215418 · Cited by 417
Pastorelli, L., Garg, R. R., Hoang, S. B., Spina, L., Mattioli, B., Scarpa, M., Fiocchi, C., Vecchi, M., & Pizarro, T. T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912678107 · Cited by 415
Asthma and Allergic Inflammation
Locksley, R. M. (2010) · Cell · doi:10.1016/j.cell.2010.03.004 · Cited by 408
IL-33–activated dendritic cells induce an atypical TH2-type response
Rank, M. A., Kobayashi, T., Kozaki, H., Bartemes, K. R., Squillace, D. L., & Kita, H. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.02.026 · Cited by 399
Doherty, T. A., Khorram, N., Lund, S., Mehta, A. K., Croft, M., & Broide, D. H. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.03.048 · Cited by 393
Perinatal Activation of the Interleukin-33 Pathway Promotes Type 2 Immunity in the Developing Lung
de Kleer, I. M., Kool, M., de Bruijn, M. J. W., Willart, M., van Moorleghem, J., Schuijs, M. J., Plantinga, M., Beyaert, R., Hams, E., Fallon, P. G., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.031 · Cited by 341
Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33
Cayrol, C., Duval, A., Schmitt, P., Roga, S., Camus, M., Stella, A., Burlet-Schiltz, O., Gonzalez-de-Peredo, A., & Girard, J.-P. (2018) · Nature Immunology · doi:10.1038/s41590-018-0067-5 · Cited by 340
Bourgeois, E., Van, L. P., Samson, M., Diem, S., Barra, A., Roga, S., Gombert, J., Schneider, E., Dy, M., Gourdy, P., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200838575 · Cited by 329
Liu, B., Tai, Y., Achanta, S., Kaelberer, M. M., Caceres, A. I., Shao, X., Fang, J., & Jordt, S.-E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606608113 · Cited by 323
IL‐33 is a chemoattractant for human Th2 cells
Komai‐Koma, M., Xu, D., Li, Y., McKenzie, A. N. J., McInnes, I. B., & Liew, F. Y. (2007) · European Journal of Immunology · doi:10.1002/eji.200737547 · Cited by 319
Interleukin-33 – cytokine of dual function or novel alarmin?
Haraldsen, G., Balogh, J., Pollheimer, J., Sponheim, J., & Küchler, A. M. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.03.003 · Cited by 308
Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
Cohen, E. S., Scott, I. C., Majithiya, J. B., Rapley, L., Kemp, B. P., England, E., Rees, D. G., Overed-Sayer, C. L., Woods, J., Bond, N. J., et al. (2015) · Nature Communications · doi:10.1038/ncomms9327 · Cited by 270
IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma
Saglani, S., Lui, S., Ullmann, N., Campbell, G. A., Sherburn, R. T., Mathie, S. A., Denney, L., Bossley, C. J., Oates, T., Walker, S. A., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.04.012 · Cited by 258
First-Breath-Induced Type 2 Pathways Shape the Lung Immune Environment
Saluzzo, S., Gorki, A.-D., Rana, B. M. J., Martins, R., Scanlon, S., Starkl, P., Lakovits, K., Hladik, A., Korosec, A., Sharif, O., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.071 · Cited by 255
Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis
Kobori, A., Yagi, Y., Imaeda, H., Ban, H., Bamba, S., Tsujikawa, T., Saito, Y., Fujiyama, Y., & Andoh, A. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0245-1 · Cited by 250
Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease
Beltrán, C. J., Núñez, L. E., Díaz-Jiménez, D., Farfan, N., Candia, E., Heine, C., López, F., González, M. J., Quera, R., & Hermoso, M. A. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21175 · Cited by 238
Moritz, D. R., Rodewald, H.-R., Gheyselinck, J., & Klemenz, R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4866 · Cited by 233
Mast cells signal their importance in health and disease
Olivera, A., Beaven, M. A., & Metcalfe, D. D. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.01.034 · Cited by 223
Regulation of type 2 innate lymphoid cell–dependent airway hyperreactivity by butyrate
Thio, C. L.-P., Chi, P.-Y., Lai, A. C.-Y., & Chang, Y.-J. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.02.032 · Cited by 218
IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by targeting mast cells
Galand, C., Leyva-Castillo, J. M., Yoon, J., Han, A., Lee, M. S., McKenzie, A. N. J., Stassen, M., Oyoshi, M. K., Finkelman, F. D., & Geha, R. S. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.03.056 · Cited by 211
Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils
Suzukawa, M., Koketsu, R., Iikura, M., Nakae, S., Matsumoto, K., Nagase, H., Saito, H., Matsushima, K., Ohta, K., Yamamoto, K., et al. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.82 · Cited by 205
Savenije, O. E., Mahachie John, J. M., Granell, R., Kerkhof, M., Dijk, F. N., de Jongste, J. C., Smit, H. A., Brunekreef, B., Postma, D. S., Van Steen, K., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.12.1080 · Cited by 185
Non-IgE mediated mast cell activation
Yu, Y., Blokhuis, B. R., Garssen, J., & Redegeld, F. A. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.07.017 · Cited by 183
More alternative activation of macrophages in lungs of asthmatic patients
Melgert, B. N., ten Hacken, N. H., Rutgers, B., Timens, W., Postma, D. S., & Hylkema, M. N. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.045 · Cited by 176
Lee, Y. G., Jeong, J. J., Nyenhuis, S., Berdyshev, E., Chung, S., Ranjan, R., Karpurapu, M., Deng, J., Qian, F., Kelly, E. A. B., et al. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0255oc · Cited by 174
IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma
Smith, D. E. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03384.x · Cited by 173
Sponheim, J., Pollheimer, J., Olsen, T., Balogh, J., Hammarström, C. L., Loos, T., Kasprzycka, M., Sørensen, D. R., Nilsen, H. R., Küchler, A. M., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100378 · Cited by 172
T-bet– and STAT4–dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses
Baumann, C., Bonilla, W. V., Fröhlich, A., Helmstetter, C., Peine, M., Hegazy, A. N., Pinschewer, D. D., & Löhning, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418549112 · Cited by 169
Mast cell proteases as pharmacological targets
Caughey, G. H. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.04.045 · Cited by 165
IL-33 Precedes IL-5 in Regulating Eosinophil Commitment and Is Required for Eosinophil Homeostasis
Johnston, L. K., Hsu, C.-L., Krier-Burris, R. A., Chhiba, K. D., Chien, K. B., McKenzie, A., Berdnikovs, S., & Bryce, P. J. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600611 · Cited by 162
Espinassous, Q., Paco, E. G. D., García-Verdugo, I., Synguélakis, M., von Aulock, S., Sallenave, J., McKenzie, A. N. J., & Kanellopoulos, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803067 · Cited by 158
IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38α-dependent pathway
Kroeger, K. M., Sullivan, B. M., & Locksley, R. M. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0708452 · Cited by 158
Alternative splicing of interleukin-33 and type 2 inflammation in asthma
Gordon, E. D., Simpson, L. J., Rios, C. L., Ringel, L., Lachowicz-Scroggins, M. E., Peters, M. C., Wesolowska-Andersen, A., Gonzalez, J. R., MacLeod, H. J., Christian, L. S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601914113 · Cited by 153
The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells
Weng, Z., Patel, A., Panagiotidou, S., & Theoharides, T. C. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.032 · Cited by 150
IL-33 is upregulated in colonocytes of ulcerative colitis
Seidelin, J. B., Bjerrum, J. T., Coskun, M., Widjaya, B., Vainer, B., & Nielsen, O. H. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.11.001 · Cited by 147
Wong, C. K., Cheung, P. F., & Lam, C. W. K. (2007) · European Journal of Immunology · doi:10.1002/eji.200636866 · Cited by 143
Self-citationTeufelberger, A. R., Nordengrün, M., Braun, H., Maes, T., Grove, K. C. D., Holtappels, G., O'Brien, C., Provoost, S., Hammad, H., Gonçalves, A. C., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.05.004 · Cited by 139
Cheung, P. F., Wong, C. K., Ho, A. M. ‐., Hu, S., Chen, D.-P., & Lam, C. W.-K. (2010) · International Immunology · doi:10.1093/intimm/dxq027 · Cited by 137
Self-citationTsang, M. S., Jiao, D., Chan, B. C.-L., Hon, K. E., Leung, P. C., Lau, C. B., Wong, E., Cheng, L., Chan, C. W. H., Lam, C. W. K., et al. (2016) · Molecules · doi:10.3390/molecules21040519 · Cited by 137
Self-citationThe biological paths of IL-1 family members IL-18 and IL-33
Smith, D. E. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0810470 · Cited by 135
Roy, A., Ganesh, G., Sippola, H., Bolin, S., Sawesi, O., Dagälv, A., Schlenner, S., Feyerabend, T. B., Rodewald, H.-R., Kjellén, L., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.435156 · Cited by 133
Shen, Z.-J., Esnault, S. J., & Malter, J. S. (2005) · Nature Immunology · doi:10.1038/ni1266 · Cited by 129
Liu, T., Kanaoka, Y., Barrett, N. A., Feng, C., Garofalo, D., Lai, J., Buchheit, K. M., Bhattacharya, N., Laidlaw, T. M., Katz, H. R., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500905 · Cited by 128
IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs
Chen, C., Kobayashi, T., Iijima, K., Hsu, F., & Kita, H. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.015 · Cited by 119
IL-33 and the intestine: The good, the bad, and the inflammatory
Hodzic, Z., Schill, E. M., Bolock, A. M., & Good, M. L. (2017) · Cytokine · doi:10.1016/j.cyto.2017.06.017 · Cited by 117
Expression of α-tryptase and β-tryptase by human basophils
Jogie-Brahim, S., Min, H.-K., Fukuoka, Y., Xia, H.-Z., & Schwartz, L. B. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.02.032 · Cited by 113
Ip, W., Wong, C. K., Li, M. L. Y., Li, P. W., Cheung, P. F., & Lam, C. W. K. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02668.x · Cited by 109
Self-citationType 2 Innate Lymphoid Cells in Allergic Disease
Lund, S. J., Walford, H., & Doherty, T. A. (2014) · Current Immunology Reviews · doi:10.2174/1573395510666140304235916 · Cited by 106
Group 2 Innate Lymphoid Cells in Pulmonary Immunity and Tissue Homeostasis
Mindt, B. C., Fritz, J. H., & Duerr, C. U. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00840 · Cited by 104
Wong, C. K., Leung, K. M.-L., Qiu, H., Chow, J. L., Choi, A. O. K., & Lam, C. W.-K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029815 · Cited by 103
Self-citationWaern, I., Jonasson, S., Hjoberg, J., Bucht, A., Åbrink, M., Pejler, G., & Wernersson, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900180 · Cited by 102
Activated mast cells synthesize and release soluble ST2‐a decoy receptor for IL‐33
Bandara, G., Beaven, M. A., Olivera, A., Gilfillan, A. M., & Metcalfe, D. D. (2015) · European Journal of Immunology · doi:10.1002/eji.201545501 · Cited by 100
Nabekura, T., Girard, J., & Lanier, L. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500424 · Cited by 96
Chow, J. L., Wong, C. K., Cheung, P. F., & Lam, C. W. (2009) · Cellular and Molecular Immunology · doi:10.1038/cmi.2009.106 · Cited by 94
Self-citationIL-33/ST2 axis promotes mast cell survival via BCLXL
Wang, J., Kaieda, S., Ameri, S., Fishgal, N., Dwyer, D. F., Dellinger, A. L., Kepley, C. L., Gurish, M. F., & Nigrovic, P. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404182111 · Cited by 92
Jiao, D., Wong, C. K., Qiu, H., Dong, J., Cai, Z., Chu, M., Hon, K. E., Tsang, M. S., & Lam, C. W.-K. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.77 · Cited by 89
Self-citationNechama, M., Kwon, J., Wei, S., Tun-Kyi, A., Welner, R. S., Ben‐Dov, I. Z., Arredouani, M. S., Asara, J. M., Chen, C.-H., Tsai, C.-Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03886-6 · Cited by 88
Role of interleukin 33 in respiratory allergy and asthma
Makrinioti, H., Toussaint, M., Jackson, D. J., Walton, R. P., & Johnston, S. L. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70261-3 · Cited by 83
Fu, Z., Thorpe, M., Alemayehu, R., Roy, A., Kervinen, J., de Garavilla, L., Åbrink, M., & Hellman, L. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601223 · Cited by 75
Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies
Katial, R. K., Bensch, G. W., Busse, W. W., Chipps, B. E., Denson, J. L., Gerber, A. N., Jacobs, J., Kraft, M., Martin, R. J., Nair, P. K., et al. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.11.029 · Cited by 74
Liu, T., Barrett, N. A., Kanaoka, Y., Yoshimoto, E., Garofalo, D., Cirka, H., Feng, C., & Boyce, J. A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700603 · Cited by 74
Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases
Chen, W., Tsai, T., Yang, J., & Li, L. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492885 · Cited by 73
Patel, A., Tsilioni, I., Weng, Z., & Theoharides, T. C. (2017) · Experimental Dermatology · doi:10.1111/exd.13461 · Cited by 69
Wang, X., Jiang, X., Yu, X., Liu, H., Tao, Y., Jiang, G., & Hong, M. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13204 · Cited by 68
Interleukin (IL)-33: New Therapeutic Target for Atopic Diseases
Nabe, T. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.14r12cp · Cited by 65
Zoltowska, A., Lei, Y., Fuchs, B., Rask, C., Adner, M., & Nilsson, G. P. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12683 · Cited by 65
Adrenoceptor-mediated enhancement of interleukin-33 production by dendritic cells
Yanagawa, Y., Matsumoto, M., & Togashi, H. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.04.012 · Cited by 63
IL-33 is regulated by TNF-α in normal and psoriatic skin
Balato, A., Caprio, R. D., Canta, L., Mattii, M., Lembo, S., Raimondo, A., Schiattarella, M., Balato, N., & Ayala, F. (2014) · Archives of Dermatological Research · doi:10.1007/s00403-014-1447-9 · Cited by 61
Liu, K., Hu, S., Chan, B. C.-L., Wat, E., Lau, C. B., Hon, K. E., Fung, K., Leung, P., Hui, C. L., Lam, C. W. K., et al. (2013) · Molecules · doi:10.3390/molecules18032483 · Cited by 60
Self-citationIL-33 and Its Receptor ST2 after Inhaled Allergen Challenge in Allergic Asthmatics
Mitchell, P. D., Salter, B., Oliveria, J. P., El-Gammal, A. I., Tworek, D., Smith, S. G., Sehmi, R., Gauvreau, G. M., & O’Byrne, P. M. (2018) · International Archives of Allergy and Immunology · doi:10.1159/000488015 · Cited by 57
Kouzaki, H., Matsumoto, K., Kikuoka, H., Kato, T., Tojima, I., Shimizu, S., Kita, H., & Shimizu, T. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201603-0529oc · Cited by 56
Group 2 Innate Lymphoid Cells in the Lung
Drake, L. Y., & Kita, H. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800147-9.00001-7 · Cited by 48
Jung, Y., Kim, J., Park, N.-J., Bong, S.-K., Lee, S., Jegal, H., Jin, L. T., Kim, S. M., Kim, Y. K., & Kim, S.-N. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.098 · Cited by 44
Interleukin-33 and Inflammatory Bowel Diseases: Lessons from Human Studies
Nunes, T., Bernardazzi, C., & de Souza, H. S. P. (2014) · Mediators of Inflammation · doi:10.1155/2014/423957 · Cited by 43
Interleukin-33 mediates formalin-induced inflammatory pain in mice
Han, P., Zhao, J., Liu, S.-B., Yang, C.-J., Wang, Y., Wu, G. C., Xu, D., & Mi, W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.03.019 · Cited by 40
IL-33-induced alternatively activated macrophage attenuates the development of TNBS-induced colitis
Tu, L., Chen, J., Xu, D., Xie, Z., Yu, B., Tao, Y., Shi, G., & Duan, L. (2017) · Oncotarget · doi:10.18632/oncotarget.15984 · Cited by 40
Wong, C. K., Ng, S. S. M., Lun, S. W., Cao, J., & Lam, C. W. K. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02916.x · Cited by 39
Self-citationJohansson, K., Malmhäll, C., Ramos‐Ramírez, P., & Rådinger, M. (2017) · Immunology · doi:10.1111/imm.12842 · Cited by 39
Yazdani, R., Sharifi, M., Shirvan, A. S., Azizi, G., & Ganjalıkhani-Hakemi, M. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.09.006 · Cited by 38
Protostemonine attenuates alternatively activated macrophage and DRA-induced asthmatic inflammation
Song, Y., Wu, Y., Li, X., Shen, Y., Ding, Y., Zhu, H., Liu, F., Yu, K., Sun, L., & Qian, F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.003 · Cited by 36
Jang, T. Y., & Kim, Y. H. (2015) · International Neurourology Journal · doi:10.5213/inj.2015.19.3.142 · Cited by 35
Leung, T. F., Wong, K. Y., Wong, C. K., Fung, K., Lam, C. W. K., Fok, T. F., Leung, P. C., & Hon, K. E. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08502.x · Cited by 35
Self-citationEupatilin with PPARα agonistic effects inhibits TNFα-induced MMP signaling in HaCaT cells
Jung, Y., Kim, J., Choi, Y.-S., Lee, S., Kang, K. S., Kim, Y. K., & Kim, S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.043 · Cited by 34
Non-pulmonary allergic diseases and inflammatory bowel disease: A qualitative review
Kotlyar, D. S., Shum, M., Hsieh, J., Blonski, W., & Greenwald, D. A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11023 · Cited by 33
Tolerability and benefit of a tetramethoxyluteolin-containing skin lotion
Theoharides, T. C., Stewart, J. M., & Tsilioni, I. (2017) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632017707610 · Cited by 29
The role of interleukin-33 in pathogenesis of bronchial asthma. New experimental data
Khaitov, M. R., Гайсина, А. Р., Shilovskiy, I. P., Vv, S., Ramenskaya, G. V., Nikonova, A. A., & Khaitov, R. M. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918010029 · Cited by 29
IL-33 in clinical practice: Size matters?
Morita, H., Nakae, S., Saito, H., & Matsumoto, K. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.03.042 · Cited by 28
Chan, B. C.-L., Li, L., Hu, S. Q., Wat, E., Wong, E., Zhang, V., Lau, C. B., Wong, C. K., Hon, K. E., Hui, C. L., et al. (2015) · Molecules · doi:10.3390/molecules200916388 · Cited by 25
Self-citationDong, M., Ma, C., Wang, W., Chen, J., & Wei, Y. (2018) · Acupuncture in Medicine · doi:10.1136/acupmed-2017-011377 · Cited by 23
Hirahara, K., Mato, N., Hagiwara, K., & Nakayama, T. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr1117-456r · Cited by 23
IL-33/ST2 signaling boosts inflammation and pain
Fattori, V., Borghi, S. M., & Verri, W. A., Jr. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716120114 · Cited by 21
Antibody therapy for the management of severe asthma with eosinophilic inflammation
Ohta, K., Nagase, H., Suzukawa, M., & Ohta, S. (2017) · International Immunology · doi:10.1093/intimm/dxx045 · Cited by 20
Jeon, W., Shin, H., Shin, I., Kim, S. K., & Lee, M.-Y. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0857-3 · Cited by 18
The IL-33/ST2 axis: yet another therapeutic target in inflammatory bowel disease?
Salas, A. (2013) · Gut · doi:10.1136/gutjnl-2012-303920 · Cited by 16
Li, J., Saruta, K., Dumouchel, J. P., Magat, J. M., Thomas, J. L., Ajami, D., Rebek, M., REBEK, J. J., & Bigby, T. D. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700693 · Cited by 13
Fursov, N., Lü, J., Healy, C., Wu, S., Lacy, E. R., Filer, A., Li, Y., Liu, C., Lamb, R. J., Jones, B. H., et al. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.05.019 · Cited by 8
Park, C., Jang, T. Y., Heo, M.-J., Jung, A.-Y., & Kim, Y. H. (2015) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2015.29.4251 · Cited by 4
Cited by
The basic immunology of asthma
Hammad, H., & Lambrecht, B. N. (2021) · Cell · doi:10.1016/j.cell.2021.02.016 · Cited by 1,105
Endometriosis: Etiology, pathobiology, and therapeutic prospects
Saunders, P. T. K., & Horne, A. W. (2021) · Cell · doi:10.1016/j.cell.2021.04.041 · Cited by 961
Pang, J., Feng, J. N., Ling, W., & Jin, T. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.06.003 · Cited by 52
Helminth Therapy for Immune-Mediated Inflammatory Diseases: Current and Future Perspectives
Shi, W., Xu, N., Wang, X., Vallée, I., Liu, M., & Liu, X. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s348079 · Cited by 46
Halogenation Activity of Mammalian Heme Peroxidases
Arnhold, J., & Malle, E. (2022) · Antioxidants · doi:10.3390/antiox11050890 · Cited by 40
Metadata
- Authors
- Chan, B. C. L., Lam, C. W. K., Tam, L.-S., & Wong, C. K.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-03-04
- Volume
- 10
- Pages
- 364-364
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2920788708
- Cited by
- 285
- References
- 125
- FWCI
- 11.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.